Development Level

Tbio 2 | 11,445
Tchem 1 | 1,598

Disease

Carcinoma 3 | 11,493
breast carcinoma 2 | 1,638
diabetes mellitus 2 | 1,728
invasive ductal carcinoma 2 | 2,951
lung carcinoma 2 | 2,843
ovarian cancer 2 | 8,520
AIDS-Related Opportunistic Infections 1 | 1
Abnormal thrombosis 1 | 6
Abnormality of T cells 1 | 2
Active peptic ulcer disease 1 | 3
Alcoholic Intoxication, Chronic 1 | 289
Anemia 1 | 365
Angiodysplasia 1 | 5
Aortic valve stenosis 1 | 28
Atherosclerosis 1 | 291
Atrial Fibrillation 1 | 124
Bernard-Soulier syndrome 1 | 14
Bleeding time prolonged 1 | 31
Breast Neoplasms 1 | 445
Cancer 1 | 2,499
Cardiovascular Diseases 1 | 59
Cerebrovascular disease 1 | 238
Chemical and Drug Induced Liver Injury 1 | 195
Coagulation time prolonged 1 | 4
Congenital afibrinogenemia 1 | 11
Coronary artery disease 1 | 268
Cytomegalovirus retinitis 1 | 2
Decreased platelet count 1 | 111
Diabetic retinopathy 1 | 56
Disseminated intravascular coagulation 1 | 38
Down syndrome 1 | 499
Ecchymosis 1 | 66
Epistaxis 1 | 43
Factor VIII deficiency 1 | 10
Factor XI Deficiency 1 | 12
Factor XIII deficiency 1 | 6
Gastrointestinal Hemorrhage 1 | 52
Gastrointestinal angiodysplasia 1 | 3
Gastrointestinal system disease 1 | 54
Glanzmann's thrombasthenia 1 | 23
Heart disease 1 | 306
Heart failure 1 | 162
Hemarthrosis 1 | 12
Hemophilia B 1 | 11
Hepatic veno-occlusive disease 1 | 16
Highly variable severity 1 | 157
Human immunodeficiency virus infectious disease 1 | 138
Hypersensitivity reaction type II disease 1 | 253
Hypertension 1 | 396
Hypothyroidism 1 | 122
Impaired platelet aggregation 1 | 8
Increased tendency to bruise 1 | 66
Intermittent claudication 1 | 20
Intracranial Thrombosis 1 | 3
Kidney disease 1 | 430
Liver Cirrhosis, Experimental 1 | 769
Liver disease 1 | 237
Lung disease 1 | 142
Lymphopenia 1 | 67
Mammary Neoplasms 1 | 425
Melanoma 1 | 711
Menorrhagia 1 | 25
Mitral Valve Prolapse Syndrome 1 | 39
Muscular Dystrophy, Duchenne 1 | 7
Nerve Degeneration 1 | 121
Okt4 Epitope Deficiency 1 | 1
Peripheral vascular disease 1 | 87
Persistent bleeding after trauma 1 | 6
Pneumocystosis 1 | 17
Polyclonal hypergammaglobulinemia 1 | 5
Protein C deficiency 1 | 19
Pulmonary embolism 1 | 55
Purpura 1 | 43
Reduced factor VIII activity 1 | 3
Skin cancer 1 | 469
Thrombocytopenia 1 | 197
Thrombocytosis 1 | 38
Thrombophilia 1 | 38
Thrombosis 1 | 46
Thrombotic thrombocytopenic purpura 1 | 14
Variable expressivity 1 | 157
Vascular disease 1 | 319
Vasculitis 1 | 80
Von Willebrand's disease 1 | 19
Von Willebrand's factor activity decreased 1 | 2
adrenocortical carcinoma 1 | 1,428
alcohol use disorder 1 | 12
lung adenocarcinoma 1 | 2,716
pancreatic cancer 1 | 2,398
pediatric high grade glioma 1 | 1,064
sarcoidosis 1 | 370
subependymal giant cell astrocytoma 1 | 2,287
urothelial carcinoma 1 | 318
von Willebrand Disease, Type 1 1 | 1
von Willebrand Disease, Type 2 1 | 1
von Willebrand Disease, Type 2A 1 | 1
von Willebrand Disease, Type 2B 1 | 1
von Willebrand Disease, Type 2N 1 | 1
von Willebrand Disease, Type 3 1 | 1
von Willebrand disease type 2M 1 | 1

Tissue

Digestive Tract 3 | 17,369
Endocrine System 3 | 18,159
Female tissues 3 | 17,400
Liver and Pancreas 3 | 16,750
Skin and soft tissues 3 | 17,230
Urinary Tract 3 | 16,678
Blood and immune system 2 | 16,909
Cardiovascular System 2 | 15,192
Male tissues 2 | 17,142
Nervous System 2 | 16,725
Respiratory system 2 | 16,393

Target Family

Non-IDG 3 | 12,091

GO Function

immunoglobulin binding 3 | 3
metal ion binding 2,256 | 2,256
DNA binding 1,481 | 1,481
ATP binding 1,477 | 1,477
RNA binding 1,383 | 1,383
identical protein binding 1,084 | 1,084
zinc ion binding 828 | 828
transcription factor activity,... 816 | 816
protein homodimerization activ... 801 | 801
calcium ion binding 690 | 690
G-protein coupled receptor act... 658 | 658
protein heterodimerization act... 473 | 473
olfactory receptor activity 425 | 425
protein kinase binding 410 | 410
chromatin binding 378 | 378
receptor binding 374 | 374
sequence-specific DNA binding 374 | 374
GTP binding 372 | 372
protein serine-threonine kinas... 360 | 360
RNA polymerase II core promote... 346 | 346
enzyme binding 340 | 340
ubiquitin protein ligase bindi... 301 | 301
transcription factor binding 297 | 297
GTPase activity 286 | 286
GTPase activator activity 281 | 281
cadherin binding 277 | 277
transcriptional activator acti... 274 | 274
actin binding 272 | 272
ubiquitin-protein transferase ... 260 | 260
transcription coactivator acti... 249 | 249
serine-type endopeptidase acti... 246 | 246
protein domain specific bindin... 241 | 241
protein complex binding 231 | 231
structural molecule activity 229 | 229
microtubule binding 212 | 212
nucleic acid binding 210 | 210
signal transducer activity 208 | 208
transcription regulatory regio... 205 | 205
RNA polymerase II regulatory r... 204 | 204
receptor activity 202 | 202
transmembrane signaling recept... 202 | 202
ubiquitin protein ligase activ... 202 | 202
transcription corepressor acti... 200 | 200
magnesium ion binding 197 | 197
calmodulin binding 194 | 194
protein C-terminus binding 191 | 191
protein kinase activity 182 | 182
carbohydrate binding 178 | 178
RNA polymerase II transcriptio... 174 | 174
cytokine activity 171 | 171
antigen binding 169 | 169
growth factor activity 162 | 162
heparin binding 161 | 161
protein dimerization activity 161 | 161
structural constituent of ribo... 161 | 161
actin filament binding 151 | 151
iron ion binding 139 | 139
transcriptional activator acti... 139 | 139
Rab GTPase binding 138 | 138
transcriptional repressor acti... 135 | 135
transporter activity 134 | 134
heme binding 129 | 129
ATPase activity 128 | 128
lipid binding 127 | 127
SH3 domain binding 125 | 125
protein tyrosine kinase activi... 122 | 122
ion channel binding 118 | 118
mRNA binding 118 | 118
Ras guanyl-nucleotide exchange... 116 | 116
metalloendopeptidase activity 115 | 115
unfolded protein binding 113 | 113
integrin binding 112 | 112
histone binding 111 | 111
protease binding 108 | 108
histone deacetylase binding 107 | 107
structural constituent of cyto... 107 | 107
guanyl-nucleotide exchange fac... 106 | 106
protein N-terminus binding 106 | 106
peptide antigen binding 103 | 103
hormone activity 96 | 96
serine-type endopeptidase inhi... 96 | 96
odorant binding 94 | 94
kinase binding 92 | 92
single-stranded DNA binding 92 | 92
chaperone binding 91 | 91
oxidoreductase activity 91 | 91
protein tyrosine phosphatase a... 91 | 91
PDZ domain binding 87 | 87
thiol-dependent ubiquitinyl hy... 86 | 86
kinase activity 84 | 84
transcriptional repressor acti... 84 | 84
beta-catenin binding 83 | 83
hydrolase activity 80 | 80
peptidase activity 80 | 80
protein binding, bridging 80 | 80
ATPase binding 79 | 79
double-stranded DNA binding 79 | 79
phospholipid binding 78 | 78
phosphatidylinositol binding 77 | 77
thiol-dependent ubiquitin-spec... 76 | 76
drug binding 75 | 75

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
von Willebrand factor VWF Tbio Non-IDG -3.93535 9001.4 1081
T-cell surface glycoprotein CD4 CD4 Tchem Non-IDG -2.62762 407.9 4422
Histidine-rich glycoprotein HRG Tbio Non-IDG -2.43021 294.3 219